Intelligence Profile
Research Papers
Research on glycerol tributyrate, while not abundantly detailed, highlights its investigation primarily in animal models and a prospective clinical trial. Here is a synthesis of the key findings:
Tributyrin in Animal Studies: Two recent studies explored tributyrin, a related compound to glycerol tributyrate, in animals. One study in young pigeons assessed tributyrin's impact on immune function and antioxidant capacity. The study observed potential benefits, suggesting enhanced immune responses and improved antioxidant status (PMID: 42193838). Another study examined tributyrin's effects in juvenile Pacific White Shrimp fed high-soybean-meal diets. Results indicated improvements in growth, immune parameters, and intestinal morphology, suggesting beneficial effects on overall health and performance (PMID: 42193789).
Clinical Trials: A clinical trial (NCT06792500) is planned for glycerol tributyrate, focusing on its use in patients with mitochondrial disorders like MELAS and LHON-Plus. This Phase 1/Phase 2 trial is not yet recruiting, marking the beginning of clinical evaluation for glycerol tributyrate in these conditions.
Disclaimer: This information is for educational purposes only and should not be used as medical advice. For health concerns, consult a healthcare professional.